Clinical Trials

PSMAddition: An International Prospective Open-label, Randomized, Phase III Study comparing 177Lu-PSMA-617 in combination with Standard of Care, versus Standard of Care alone, in adult male patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

John Sarantopoulos MD

For more information about this study
View Details

About This Study